Cargando…
Impact of Palliative Care in Evaluating and Relieving Symptoms in Patients with Advanced Cancer. Results from the DEMETRA Study
Background: Cancer patients experience multiple symptoms throughout the course of the disease. We aimed to provide a comprehensive analysis of the symptom burden in patients with advanced cancer at admission to specialist palliative care (PC) services and seven days later to estimate the immediate i...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7698052/ https://www.ncbi.nlm.nih.gov/pubmed/33202542 http://dx.doi.org/10.3390/ijerph17228429 |
_version_ | 1783615740915482624 |
---|---|
author | Corli, Oscar Pellegrini, Giacomo Bosetti, Cristina Riva, Luca Crippa, Matteo Amodio, Emanuele Scaccabarozzi, Gianlorenzo |
author_facet | Corli, Oscar Pellegrini, Giacomo Bosetti, Cristina Riva, Luca Crippa, Matteo Amodio, Emanuele Scaccabarozzi, Gianlorenzo |
author_sort | Corli, Oscar |
collection | PubMed |
description | Background: Cancer patients experience multiple symptoms throughout the course of the disease. We aimed to provide a comprehensive analysis of the symptom burden in patients with advanced cancer at admission to specialist palliative care (PC) services and seven days later to estimate the immediate impact of PC intervention. Patient and methods: The analysis was based on an observational, prospective, multicenter study (named DEMETRA) conducted in Italy on new patients accessing network specialist PC centers during the period May 2017–November 2017. The prevalence and intensity of symptoms were assessed at baseline and after seven days using three tools including the Edmonton Symptom Assessment System (ESAS). Results: Five PC centers recruited 865 cancer patients. Thirty-three different symptoms were observed at the baseline, the most frequent being asthenia (84.9%) and poor well-being (71%). The intensity of the most frequent symptoms according to ESAS ranged from 5.5 for asthenia to 3.9 for nausea. The presence and intensity of physical symptoms increased with increasing levels of anxiety and depression. After seven days, prevalence of nausea and breathlessness as well as intensity of almost all symptoms significantly decreased. Conclusions: The study confirmed the considerable symptom burden of patients with advanced cancer. PC intervention has significantly reduced the severity of symptoms, despite the patients’ advanced disease and short survival. |
format | Online Article Text |
id | pubmed-7698052 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-76980522020-11-29 Impact of Palliative Care in Evaluating and Relieving Symptoms in Patients with Advanced Cancer. Results from the DEMETRA Study Corli, Oscar Pellegrini, Giacomo Bosetti, Cristina Riva, Luca Crippa, Matteo Amodio, Emanuele Scaccabarozzi, Gianlorenzo Int J Environ Res Public Health Article Background: Cancer patients experience multiple symptoms throughout the course of the disease. We aimed to provide a comprehensive analysis of the symptom burden in patients with advanced cancer at admission to specialist palliative care (PC) services and seven days later to estimate the immediate impact of PC intervention. Patient and methods: The analysis was based on an observational, prospective, multicenter study (named DEMETRA) conducted in Italy on new patients accessing network specialist PC centers during the period May 2017–November 2017. The prevalence and intensity of symptoms were assessed at baseline and after seven days using three tools including the Edmonton Symptom Assessment System (ESAS). Results: Five PC centers recruited 865 cancer patients. Thirty-three different symptoms were observed at the baseline, the most frequent being asthenia (84.9%) and poor well-being (71%). The intensity of the most frequent symptoms according to ESAS ranged from 5.5 for asthenia to 3.9 for nausea. The presence and intensity of physical symptoms increased with increasing levels of anxiety and depression. After seven days, prevalence of nausea and breathlessness as well as intensity of almost all symptoms significantly decreased. Conclusions: The study confirmed the considerable symptom burden of patients with advanced cancer. PC intervention has significantly reduced the severity of symptoms, despite the patients’ advanced disease and short survival. MDPI 2020-11-14 2020-11 /pmc/articles/PMC7698052/ /pubmed/33202542 http://dx.doi.org/10.3390/ijerph17228429 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Corli, Oscar Pellegrini, Giacomo Bosetti, Cristina Riva, Luca Crippa, Matteo Amodio, Emanuele Scaccabarozzi, Gianlorenzo Impact of Palliative Care in Evaluating and Relieving Symptoms in Patients with Advanced Cancer. Results from the DEMETRA Study |
title | Impact of Palliative Care in Evaluating and Relieving Symptoms in Patients with Advanced Cancer. Results from the DEMETRA Study |
title_full | Impact of Palliative Care in Evaluating and Relieving Symptoms in Patients with Advanced Cancer. Results from the DEMETRA Study |
title_fullStr | Impact of Palliative Care in Evaluating and Relieving Symptoms in Patients with Advanced Cancer. Results from the DEMETRA Study |
title_full_unstemmed | Impact of Palliative Care in Evaluating and Relieving Symptoms in Patients with Advanced Cancer. Results from the DEMETRA Study |
title_short | Impact of Palliative Care in Evaluating and Relieving Symptoms in Patients with Advanced Cancer. Results from the DEMETRA Study |
title_sort | impact of palliative care in evaluating and relieving symptoms in patients with advanced cancer. results from the demetra study |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7698052/ https://www.ncbi.nlm.nih.gov/pubmed/33202542 http://dx.doi.org/10.3390/ijerph17228429 |
work_keys_str_mv | AT corlioscar impactofpalliativecareinevaluatingandrelievingsymptomsinpatientswithadvancedcancerresultsfromthedemetrastudy AT pellegrinigiacomo impactofpalliativecareinevaluatingandrelievingsymptomsinpatientswithadvancedcancerresultsfromthedemetrastudy AT bosetticristina impactofpalliativecareinevaluatingandrelievingsymptomsinpatientswithadvancedcancerresultsfromthedemetrastudy AT rivaluca impactofpalliativecareinevaluatingandrelievingsymptomsinpatientswithadvancedcancerresultsfromthedemetrastudy AT crippamatteo impactofpalliativecareinevaluatingandrelievingsymptomsinpatientswithadvancedcancerresultsfromthedemetrastudy AT amodioemanuele impactofpalliativecareinevaluatingandrelievingsymptomsinpatientswithadvancedcancerresultsfromthedemetrastudy AT scaccabarozzigianlorenzo impactofpalliativecareinevaluatingandrelievingsymptomsinpatientswithadvancedcancerresultsfromthedemetrastudy |